Role of the Goat

S
crapie is an infectious neurodegenerative disease naturally affecting sheep and goats. It belongs to the group of transmissible spongiform encephalopathies (TSEs), or prion diseases, such as Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE) in cattle, and chronic wasting disease in cervids. TSEs are characterized by the accumulation in the central nervous system (CNS) of a pathological aberrant form (PrP Sc ) of the host cellular prion protein (PrP C ) (1). Scrapie occurrence is determined mainly by the host prion protein-encoding gene (prnp) (2, 3) and the prion strain (4), thus resulting in distinct disease phenotypes (showing differences in the PrP Sc deposition pattern, incubation period, pathogenesis, or clinical signs). Sheep and goats share the same PrP C amino acid sequence, but with a variety of polymorphisms. Sheep prnp genotypes V 136 R 154 Q 171 and A 136 R 154 Q 171 are associated with highlevel susceptibility to classical scrapie, while the A 136 R 154 R 171 genotype is linked to resistance (5) (6) (7) (8) . This information was used in some European Union member states to implement selective breeding programs in order to promote the A 136 R 154 R 171 haplotype within ovine herds (9) .
In goats, half a hundred polymorphisms in the open reading frame (ORF) of the prnp gene have been described (10) (11) (12) , including some silent mutations, a three-octapeptide-repeat variant (13) , and a nonsense mutation at codon 32 (14) . Although several polymorphisms are shared by sheep and goats, to date, only some correlations between some variants of goat PrP C (goPrP C ) and susceptibility to TSE have been published. The I/M 142 amino acid substitution was associated with a slightly decreased risk of developing scrapie (15) (16) (17) and with prolonged incubation times after challenge with scrapie and BSE prions (18) . The same effect on the incubation period was attributed to the three-repeat/glycine 102 genotype (13, 18) . In natural outbreaks, goats carrying the H/R 143 polymorphism showed a partial decrease in their susceptibility to scrapie prions (15, 19) . Likewise, a low susceptibility to scrapie was also linked to the R/H 154 and R/Q 211 variants of goat PrP C (15, 20) , although the R/H 154 polymorphism also arose as a risk factor for goat atypical scrapie (21) . In addition, other PrP C variants, such as the N/D 146 and N/S 146 polymorphisms, were linked to resistance to scrapie (22) . However, the most encouraging results are those related to the Q/K 222 polymorphism. The absence or marked underrepresentation of scrapie-positive goats expressing the K 222 variant in numerous herds from different countries (11, 12, 15, 20, (22) (23) (24) (25) suggests that the K 222 -PrP C variant strongly influences goat susceptibility to TSE agents. Recently, heterozygous Q/K 222 goats were reported to show a strong resistance to classical scrapie after intracerebral (i.c.) inoculation (26) , as also reported in the accompanying article by Lacroux et al. (27) . This evidence should be reinforced by experimental data, but the large number of genetic variants harbored in the goat prnp gene hinders in vivo determination of the individual effects of the K 222 -PrP C variant in this matter.
In this work, we analyzed the role of the K 222 variant of goat PrP C in the susceptibility to prion infection. For that purpose, two transgenic mouse lines, one expressing the wild-type (wt) goat PrP C sequence and another expressing the same PrP C sequence, but with a single amino acid exchange from Q to K at codon 222, were generated. Both mouse lines were challenged i.c. with a panel of TSE isolates, and their susceptibilities were assessed and then compared.
MATERIALS AND METHODS
Ethics statement. Animal experiments were carried out in strict accordance with the recommendations in the guidelines of European Community Council Directive 86/609/EEC, and all efforts were made to minimize suffering. Experiments were approved by the Committee on the Ethics of Animal Experiments of INIA (permit number CEEA2009/003).
Transgenic mice. The procedures used to generate transgene constructs have been described elsewhere (28) . Briefly, the ORF of goat wt prnp was isolated by PCR amplification and sequenced, and the sequence was identical to the goat prnp sequence previously reported (GenBank accession number AF117316). The primers used created an XhoI restriction enzyme site adjacent to the translation start and stop sites of the goat PrP gene ORF (5=-CTCGAGATCATGGTGAAAAGCCACATAGG C-3= and 3=-CTCGAGCTATCCTACTATGAGAAAAATGAG-5=, respectively). The PCR fragment was subcloned into the pGEM-T Easy vector system (Promega) following the manufacturer's instructions. The expression vector MoPrP.Xho (29) was used for the production of transgenic mice. This vector contains the murine PrP (muPrP) promoter, exon 1, intron 1, exon 2, and 3=-untranslated sequences. The PrP ORF fragment was excised from the pGEM-T vector by using the restriction enzyme XhoI and was inserted into the MoPrP.Xho expression vector (29) , also digested with the XhoI enzyme, resulting in the plasmid pMo-GoPrP.Xho. This plasmid was mutated to generate a K 222 -PrP plasmid (pMo-GoK 222 -PrP.Xho) by using a QuikChange II XL kit (Stratagene, CA) with specific oligonucleotides (5=-GTGCATCACCCAGTACAAGAGAGAATCCCAGGC-3= and 3=-GCC TGGGATTCTCTCTTGTACTGGGTGATGCAC-5=), following the procedures described by the manufacturer. The MoPrP.Xho expression vector contains the murine wt prnp gene, including the murine prnp promoter, exon 1, intron 1, exon 2, and 3=-untranslated sequences, but not intron 2 and the murine PrP ORF.
Transgenic mouse lines were generated as previously described (28) . Briefly, transgenes were excised from their expression vectors (pMoGoPrP.Xho and pMo-GoK 222 -PrP.Xho) by use of the restriction endonuclease NotI, leading to DNA fragments of approximately 12 kb. DNAs were then purified using sodium chloride gradients as previously described (30) and resuspended in TE (10 mM Tris, pH 7.4, 0.1 mM EDTA) at a final concentration of 2 to 6 ng/ml. Finally, DNAs were microinjected into pronuclear-stage embryos collected from superovulated B6CBAF1 females mated with 129/Ola males carrying a null mutation in their endogenous PrP gene (31) .
DNAs were extracted from founders' tail biopsy specimens by use of an Extract-N-Amp tissue PCR kit (Sigma-Aldrich) following the manufacturer's instructions. The presence of the goat transgene in these founders was identified by PCR amplification using specific primers for mouse PrP exon 2 and the goat PrP ORF. The primers used were 5=-CATTCTG CCTTCCTAGTGGTACC-3= and 5=-GCTTGTTCCACTGACTGTGGC-3=. muPrP ϩ/Ϫ goPrP ϩ/Ϫ founders were backcrossed with homozygous PrP null animals (muPrP Ϫ/Ϫ ) to obtain mice homozygosis for the null mutation (muPrP Ϫ/Ϫ goPrP ϩ/Ϫ ). The absence of the murine PrP ORF in the transgenic mice thus generated was confirmed by PCR amplification using the primers 5=-ATGGCGAACCTTGGCTACTGGC-3= and 5=-GAT TATGGGTACCCCCTCCTTGG-3=.
Analysis of PrP C expression in transgenic mice. Whole brains from either mice or goats were homogenized in extraction buffer (0.5% NP-40, 1% sodium deoxycholate, 10 mM EDTA in phosphate-buffered saline [PBS], pH 7.4, with Complete protease inhibitor cocktail [Roche]). Samples were precleared by centrifugation at 2,000 ϫ g for 5 min, after which an equal volume of 2ϫ SDS reducing sample loading buffer was added to all samples, and each one was boiled for 5 min before being loaded onto an SDS-12% polyacrylamide gel. For immunoblotting experiments, the monoclonal antibodies (MAbs) FH11 (32) and 12B2 (33) were used at a concentration of 1 g/ml. FH11 recognizes the goat PrP amino-terminal region (amino acids 23 to 85), and 12B2 recognizes the 93 WGQGG 97 epitope of the goat PrP sequence. Immunocomplexes were detected using horseradish peroxidase-conjugated anti-mouse IgG. Immunoblots were developed with enhanced chemiluminescence.
Transmission studies. Transgenic mice were challenged with a panel of TSE agents, including cattle BSE, goat BSE, and different goat scrapie isolates (see Table 1 for isolate information). Inocula were prepared from infected brain tissues as 10% (wt/vol) homogenates in 5% glucose.
Groups of 6 to 9 individual identified animals (6 to 7 weeks old) were anesthetized and inoculated intracerebrally with 20 l of 10% brain homogenate in the right parietal lobe, using a 25-gauge disposable hypodermic needle. As a control, 6 or 7 animals of each line were inoculated with healthy goat brain to discard the possibility of appearance of a spontaneous prion disease. Mice were observed daily and their neurological status assessed twice a week. When the progression of the disease was evident, or at the end of their life span (Ϸ650 days), mice were euthanized for ethical reasons. During necropsy, the brain was harvested at Ϫ20°C for determination of the presence of proteinase K-resistant PrP (PrP res ) by Western blotting (WB). Survival time was expressed as the mean number of survival days postinoculation (dpi) for all the PrP res -positive mice, with the standard error included. Attack rate was determined as the proportion of PrP res -positive mice among all the mice inoculated. Western blotting. A total of 175 mg of brain tissue was homogenized in 5% glucose in distilled water in grinding tubes (Bio-Rad) and adjusted to 10% (wt/vol) by using a TeSeETM Precess 48TM homogenizer (BioRad) following the manufacturer's instructions. To determine the presence of PrP res in transgenic mouse brains, 100 l of 10% brain homogenate was analyzed by Western blotting as previously described (34) . For immunoblotting, membranes were incubated with the Sha31 MAb (35) , which recognizes the 148 YEDRYYRE 155 epitope of the goat PrP sequence. Immunocomplexes were detected with horseradish peroxidase-conjugated anti-mouse IgG (Amersham Pharmacia Biotech) after incubating the membranes for 1 h, and immunoreactivity was visualized by chemiluminescence with ECL Plus (GE Healthcare Amersham Biosciences).
Histopathological analysis. All procedures concerning the histopathological analysis of infected mouse brains were performed as previously described (36) . Brain samples were immediately fixed in neutralbuffered 10% formalin (4% 2-formaldehyde) during mouse necropsy and paraffin embedded later. After deparaffinization, 2-m-thick tissue slices were stained with hematoxylin and eosin. Lesion profiles of the brains were established following the standard method of Fraser and Dickinson (37) . Paraffin-embedded tissue (PET) blots and immunohistochemistry (IHC) were conducted as described by Andreoletti et al. (38, 39) .
RESULTS
Goat PrP
C expression in transgenic mice. Several mouse lines (founders) were obtained for each transgene (Q 222 -PrP C or K 222 -PrP C ). Founder animals also expressing the endogenous murine prnp gene (muprnp ϩ/Ϫ goprnp ϩ/Ϫ ) were crossed with prnp null mice (muprnp Ϫ/Ϫ ) to obtain transgene-hemizygous lines in a murine prnp null background (muprnp Ϫ/Ϫ goprnp ϩ/Ϫ ). The absence of murine prnp was determined by PCR using specific primers (data not shown). The PrP C expression levels in brain homogenates were then determined by serial dilution and Western blotting using the 12B2 MAb and were compared with the PrP C levels found in goat brain homogenates. The Q 222 -Tg501 and K 222 -Tg516 lines were selected based on the fact that they had PrP C expression levels in the brain similar to those in goats (Fig. 1) . In addition, both Q 222 -PrP C and K 222 -PrP C expressed in brains of transgenic mice showed electrophoretic profiles similar to that observed for PrP C from goat brain (Fig. 1) . Finally, the hemizygous Q 222 -Tg501 and K 222 -Tg516 mouse lines were used for transmission studies.
Transgenic mice expressing the K 222 -PrP variant are resistant to a broad panel of goat scrapie isolates. The Q 222 -Tg501 mouse line, expressing wild-type goat PrP C , was susceptible to all inoculated scrapie isolates. Intracerebrally challenged animals displayed a 100% attack rate, and mean survival times ranged from 250 to 650 dpi (Table 2 ). No differences were observed between the electrophoretic profiles of PrP res in the inoculated isolates and those of the PrP res present in the brains of challenged Q 222 -Tg501 mice (Fig. 2) .
In contrast, none of the K 222 -Tg516 mice succumbed to inoculation with any of the scrapie isolates (Table 2 ). These animals were sacrificed at 650 dpi, without clinical signs, and were scored PrP res negative in the brain by Western blotting. The absence of PrP res in the brain was confirmed by either IHC or PET blotting. These animals exhibited some vacuolation, mainly at the level of the dorsal medulla and the mesencephalic tegmentum. However, this vacuolation was also observed in the same areas in old Q 222 -Tg501 and K 222 -Tg516 mice inoculated with healthy goat brain. In contrast, all the infected Q 222 -Tg501 mice displayed PrP res deposits in the brain which were accompanied by histopathological alterations characteristic of prion infection (data not shown).
It is important that the Q 222 -Tg501 and K 222 -Tg516 mouse lines, both expressing similar amounts of PrP C in the brain, differ only in the Q/K 222 substitution in the PrP C sequence, thus demonstrating that this single amino acid exchange is the only muta- tion responsible for the differential susceptibility/resistance to scrapie observed between these mouse lines.
None of the Q 222 -Tg501 or K 222 -Tg516 mice inoculated with healthy brain samples succumbed to disease (Table 2 ). They were euthanized at the end of their life span (650 dpi), without either clinical signs or PrP res in the brain. Transgenic mice expressing the K 222 -PrP variant are resistant to cattle BSE but not to goat or sheep BSE. Both the Q 222 -Tg501 and K 222 -Tg516 mouse lines were fully susceptible (100% attack rate) to goat and sheep BSE isolates, displaying similar mean survival times ranging from 400 to 500 dpi (Table 2) . However, inoculation of cattle BSE isolates into Q 222 -Tg501 and K 222 -Tg516 mice produced markedly different results. While Q 222 -Tg501 mice showed a 100% attack rate and a survival time of 583 Ϯ 57 dpi, K 222 -Tg516 mice were sacrificed at the end of their life span (650 dpi), without either clinical signs or PrP res in the brain (Table 2) . Moreover, K 222 -Tg516 mice were totally susceptible to the cattle BSE agent passaged in Q 222 -Tg501 mice, with a mean survival time of 434 Ϯ 30 dpi.
Western blot analysis of brain PrP res in goat BSE isolates revealed a typical PrP res banding pattern characterized by small fragments (19-kDa fragment for the aglycosylated band) and prominent diglycosylated species. This pattern was indistinguishable from those observed for both Q 222 -Tg501 and K 222 -Tg516 mice infected with goat or sheep BSE isolates. Moreover, an identical PrP res banding pattern was observed for Q 222 -Tg501 mice inoculated with cattle BSE isolates (Fig. 3) .
Histopathological analysis confirmed the absence of both PrP res deposits and spongiform changes in the brains of all K 222 -Tg516 mice inoculated with cattle BSE isolates. However, when these mice were infected with goat BSE isolates, they exhibited PrP res deposition patterns and lesion profiles similar to those observed in Q 222 -Tg501 mice infected with either cattle or goat BSE isolates (data not shown).
Altogether, these results suggest a low transmission barrier to cattle BSE in transgenic mice expressing wild-type (Q 222 ) goat PrP C . Conversely, the K 222 amino acid substitution seemed to give rise to a transmission barrier that limited the propagation of cattle BSE prions. Nevertheless, this transmission barrier was abolished if the isolate was previously passaged in a wt goat PrP C -expressing host (sheep, goat, or Q 222 -Tg501 mouse) ( Table 2) .
Heterozygous Q/K 222 mice show lower attack rates and/or longer survival times depending on the inoculated isolate. To accurately determine the role of the K 222 -PrP variant in goat resistance/susceptibility to TSEs, K 222 -Tg516 mice were crossbred with Q 222 -Tg501 mice to generate heterozygous (Q/K 222 ) mice. These animals were inoculated intracerebrally with the same panel of TSE isolates used previously ( Table 2 ). Heterozygous Q/K 222 animals were resistant to the Goat-Sc I3 and Goat-Sc S2 isolates. These animals were sacrificed at 650 dpi, without having shown clinical signs, and no detectable PrP res was found in their brains by WB, IHC, or PET blotting. However, Q/K 222 mice succumbed to infection with the Goat-Sc F2 isolate, displaying a reduced attack rate (83.3%) and longer survival times than those observed in Q 222 -Tg501 mice. Moreover, Q/K 222 mice challenged with the Goat-Sc F10 isolate were also sacrificed at 650 dpi, without clinical signs, but PrP res was detected in their brains (Table 2) . Taken together, these results suggest that in heterozygous Q/K 222 mice, the K 222 -PrP C variant interferes with the replication of all tested scrapie agents.
When inoculated with the cattle BSE agent, heterozygous Q/K 222 animals showed prolonged survival times compared to Q 222 -Tg501 mice (Table 2) . However, goat BSE isolates displayed similar transmission features in all transgenic mouse models challenged (Q 222 -Tg501, K 222 -Tg516, and Q/K 222 mice), independent of the expressed PrP C variant, thus indicating low or nonexistent interference of the K 222 -PrP C variant with BSE agent replication.
Histopathological studies confirmed the presence of PrP res and spongiform changes in the brains of heterozygous Q/K 222 mice infected with Goat-Sc F2, Goat-Sc F10, and goat and cattle BSE isolates. PrP res deposits and vacuolation profiles in these mice were similar but not identical to those determined for Q 222 -Tg501 mice infected with the same isolates (data not shown). However, we cannot exclude the possibility that these slight differences were linked to the old age of Q/K 222 mice, since they displayed longer survival times than those of Q 222 -Tg501 mice. Further passages are necessary to make a conclusion on this point.
DISCUSSION
In this study, we use a transgenic mouse model to assess the role of the K 222 -PrP C variant in the resistance/susceptibility of goats to TSEs. For that purpose, we generated two transgenic mouse lines, expressing either the wt (Q 222 -Tg501) or the K 222 variant (K 222 -Tg516) of goat PrP C . Both mouse lines expressed similar amounts of PrP C and were challenged intracerebrally with a panel of prion isolates.
When TSE agent transmission efficiency was assessed in Q 222 -Tg501 mice, these animals showed high-level susceptibility (100% attack rate) to all the tested scrapie and BSE isolates. PrP res profiles in Western blots of all scrapie and BSE isolates were not altered after passage in these Q 222 -Tg501 mice ( Fig. 2 and 3) . Goat BSE isolates displayed a weak decrease in survival times compared with cattle BSE isolates, confirming the low transmission barrier of goats to cattle BSE previously reported for experimentally challenged goats (40) . According to these data, we propose Q 222 -Tg501 transgenic mice expressing wild-type goat PrP C as a valuable model for both studying the susceptibility/resistance of small ruminants to TSEs and characterizing TSE strains affecting these species.
In contrast to the high-level susceptibility of Q 222 -Tg501 mice, K 222 -Tg516 mice were fairly resistant to all the classical scrapie isolates inoculated, independent of their origin or PrP res signature. Since Q 222 -Tg501 mice and K 222 -Tg516 mice express exactly the same PrP C sequence, except for the Q/K 222 amino acid substitution, and have similar PrP C expression levels, we can assume that the lack of transmission efficiency of classical scrapie is linked to the K 222 amino acid. This conclusion is consistent with the results reported in the accompanying article by Lacroux et al. (27) and previous epidemiological studies carried out in different European goat scrapie outbreaks where the K 222 -PrP C variant was detected only in healthy goats (12, 15, 23, 24) . Taken together, these results suggest that the K 222 variant of goat PrP C is strongly resistant to a wide range of classical scrapie strains.
On the other hand, heterozygous Q/K 222 mice were clearly more resistant to the different scrapie isolates than Q 222 -Tg501 mice. These results support the contention that the K 222 -PrP C variant provides a dominant negative effect over the wild-type PrP C sequence. This phenomenon is consistent with the stone fence model (41) , which predicts that for a given TSE agent, the incorporation of a conversion-incompetent PrP C variant will interfere with wild-type PrP Sc replication, resulting in a lower efficacy of prion propagation. This decreased propagation efficacy would result in reduced attack rates and/or prolonged survival times, as shown in our study, and could explain the limited epidemiological evidence linking scrapie with the K 222 allele (11, 15, 22) .
BSE transmission experiments showed that mice expressing the K 222 -PrP C variant (K 222 -Tg516 mice) were resistant to cattle BSE but not to goat BSE or sheep BSE isolates ( Table 2 ). The failure of the cattle BSE isolates to be transmitted in K 222 -PrP C mice can be explained by the dual influence of both the PrP C sequence differences in prion cross-species transmission (2, 3) and the effect of the Q/K 222 amino acid substitution. In this sense, the effect of the PrP C primary sequence of the donor (bovine) is not strong enough to avoid cattle BSE replication in goat wt Q 222 -Tg501 mice. However, after the Q/K 222 substitution in K 222 -Tg516 mice, the cattle BSE agent is unable to replicate. This view is fully consistent with the fact that K 222 -Tg516 mice were susceptible to BSE only after passage in goats or Q 222 -Tg501 mice (Table 2) . Therefore, the transmission barrier toward the BSE agent is complex, being modulated not only by the K 222 allele but also by other determinants, such as the PrP amino acid differences between host and donor (goats versus cattle). Interestingly, this transmission barrier was abolished when the K 222 -PrP C variant was present in heterozygosis, indicating that for BSE, the K 222 amino acid substitution does not interfere with the conversion of wild-type Q 222 -PrP C into PrP Sc .
An inhibitory effect on prion replication of equivalent K 222 variants has also been described for other species. The human K 219 -PrP C allele (homologous to the codon 222 allele in goat PrP C ) was reported to protect humans against Creutzfeldt-Jakob disease (42) , while the equivalent K 218 variant of mouse PrP C significantly reduced the fibril aggregation kinetics and generated non-proteinase K-resistant PrP (43) . A plausible explanation for this inhibitory effect could be the insertion of an additional positive charge at codon 222, provided by the lysine amino acid (K), thus interfering with the PrP C -PrP Sc interaction and resulting in abolished or low conversion rates of PrP Sc (44) . All these considerations suggest that codon 222 must play an important role in PrP C conformation and point it out as a target for future TSE studies.
The use of transgenic mice in our transmission studies allowed us to pinpoint the Q/K 222 amino acid substitution as the unique mutation responsible for the observed resistance to TSEs, excluding other genetic factors. In addition, the intracerebral inoculation route provided the best scenario for prion replication, as the inoculum was placed directly in the target tissue. Therefore, although our procedure mimics neither the natural route of scrapie infection nor the complex pathogenesis involving prion replication in peripheral tissues, our results offer solid arguments supporting the hypothesis that the K 222 variant of goat PrP C provides strong resistance against a wide range of classical scrapie isolates and reinforce the view that the K 222 allele is a good candidate for the development of breeding programs for resistance against scrapie in commercial goat populations.
